T-Mobile stock price slides into the weekend as Feb. 11 earnings update looms

T-Mobile stock price slides into the weekend as Feb. 11 earnings update looms

T-Mobile US shares fell 2.2% to $197.39 Friday, underperforming peers ahead of its Feb. 11 earnings and capital markets day. The stock ended 29% below its 52-week high as investors await updated 2026–27 targets from CEO Srini Gopalan. Verizon sued T-Mobile over ad claims, which T-Mobile said it will defend. U.S. jobs and inflation data, delayed by a government shutdown, are due next week.
China Mobile Class A (600941) price: BeiDou satellite SMS roll-out in focus before Shanghai reopens

China Mobile Class A (600941) price: BeiDou satellite SMS roll-out in focus before Shanghai reopens

China Mobile’s Shanghai-listed shares closed at 95.11 yuan, down 0.26% Friday, as the Shanghai Composite Index slipped 0.25%. The company and rivals launched BeiDou satellite texting for use without ground networks. A new tax rule raises VAT on telecom services to 9% from 6% starting Jan. 1, 2026, which China Mobile said will impact revenue and profit.
7 February 2026
SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

SAP SE closed at 171.22 euros on Xetra Friday, up 0.43%, after disclosing its treasury shares rose above 5% of capital, reaching 61,737,035 shares. The increase follows the launch of a buyback plan worth up to 2.6 billion euros through July 2026. SAP’s U.S. shares finished at $203.34. Investors await SAP’s Integrated Report on Feb. 26 and next results on April 23.
CATL stock price rises after sodium-ion EV push; what investors watch before Shenzhen reopens

CATL stock price rises after sodium-ion EV push; what investors watch before Shenzhen reopens

CATL Class A shares closed up 1.7% at 369.11 yuan in Shenzhen on Friday, after trading between 358.01 and 372.88 yuan. Traders cited CATL’s sodium-ion battery rollout with Changan and a 2026 vehicle launch target. About 393,700 lots changed hands, with market value near 1.68 trillion yuan. Investors await Monday’s reopening and the next earnings report.
UnitedHealth stock price ticks up to $276.65 as insurer cost signals shift — what investors watch next week

UnitedHealth stock price ticks up to $276.65 as insurer cost signals shift — what investors watch next week

7 February 2026
UnitedHealth shares closed up 3% at $276.65 Friday, rebounding after Molina Healthcare’s weak 2026 outlook rattled managed-care stocks. Centene later issued a stronger 2026 profit forecast, easing some pressure. UnitedHealth traded between $263.00 and $277.74 during the session. Investors await Humana’s results Feb. 11 and a Medicare Advantage rate decision April 6.
RTX stock faces Pentagon payout curb list next week as dividend stays in play

RTX stock faces Pentagon payout curb list next week as dividend stays in play

RTX closed at $198.66 Friday, up 1.4%, after declaring a 68-cent quarterly dividend payable March 19. The Pentagon is expected to name defense contractors early next week that could face limits on dividends and buybacks under a Trump order. RTX’s Raytheon unit has been singled out as “least responsive.” Companies named would have 15 days to submit remediation plans.
Kweichow Moutai (600519) stock price slides 2.6% — what to know before China markets reopen

Kweichow Moutai (600519) stock price slides 2.6% — what to know before China markets reopen

7 February 2026
Kweichow Moutai Class A shares fell 2.6% to 1,515.01 yuan at Friday’s close in Shanghai, with about 7.9 million shares traded. A 2,500-share block trade matched the closing price. Liquor stocks broadly declined, while wholesale prices for Feitian Moutai labels rose Saturday. Investors await China’s February 11 inflation data as the next key event.
China Construction Bank Class A stock ticks up at Friday close as China data looms

China Construction Bank Class A stock ticks up at Friday close as China data looms

China Construction Bank Class A shares closed up 0.11% at 8.84 yuan in Shanghai on Friday, with around 100 million shares traded. The Shanghai Composite slipped 0.25%. Investors are watching for January inflation data on Feb. 11 and credit figures on Feb. 13 for policy signals. Premier Li Qiang called for early fiscal support to meet economic targets, state media reported.
PetroChina Class A stock rises with oil rebound — what 601857 traders watch next week

PetroChina Class A stock rises with oil rebound — what 601857 traders watch next week

PetroChina A-shares rose 2.3% to 10.77 yuan Friday, outperforming the Shanghai Composite, which fell 0.25%. Crude prices rebounded, with Brent settling at $68.05 a barrel, as traders tracked U.S.-Iran talks and new EU sanctions proposals. About 198.5 million PetroChina shares traded in the session. Investors await the company’s next earnings report later this quarter.
Nestle stock price: shares end higher as investors weigh baby formula recall, look to Feb 19 results

Nestle stock price: shares end higher as investors weigh baby formula recall, look to Feb 19 results

Nestle shares closed up 0.6% at 78.89 Swiss francs Friday, outperforming the Swiss blue-chip index. The move comes as investors track Europe’s widening infant formula recall, which has swept in Nestle and other producers. French authorities are investigating possible links to two infant deaths. Nestle’s full-year results are due Feb. 19.
Lam Research stock price jumps 8% as chip rally returns — what to watch next week

Lam Research stock price jumps 8% as chip rally returns — what to watch next week

Lam Research shares surged 8.3% to $231.01 Friday, with after-hours trading flat. The move followed a broad rally in chip stocks, pushing the PHLX semiconductor index up 5.7% as Nvidia, AMD, and Broadcom advanced. Lam announced a $0.26 quarterly dividend and a senior executive exercised 53,925 shares. Investors await U.S. jobs and inflation data next week.
Goldman Sachs stock jumps on Anthropic AI push — what to watch before Monday

Goldman Sachs stock jumps on Anthropic AI push — what to watch before Monday

Goldman Sachs shares jumped 4.3% to $928.75 Friday after confirming it is working with AI startup Anthropic on internal “AI agents.” The stock’s rally helped lift the Dow above 50,000 for the first time. Delayed U.S. jobs and inflation data are due midweek and could affect rate expectations. Goldman also filed for new structured notes tied to the Russell 2000 and S&P 500.
Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

7 February 2026
Philip Morris International closed at $182.81, up 0.45%, after raising its 2026 profit outlook on stronger nicotine pouch sales. Fourth-quarter adjusted EPS rose to $1.70, with net revenue up 6.8% to $10.36 billion. CEO Jacek Olczak said updated Zyn products are pending regulatory approval. The next dividend declaration is set for March 5, 2026.
Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.
AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop